In vitro selective modulation of cellular glutathione by a humanized native milk protein isolate in normal cells and rat mammary carcinoma model

Anticancer Research

Volumn 16, Issue 3 A, 1996, Pages 1095-1099

  Baruchel, Sylvain ^a   Viau, Ginette ^a  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Glutathione; Mammary carcinoma; Whey protein

Indexed keywords

GLUTATHIONE; MILK PROTEIN;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CELL GROWTH; CELL SELECTION; COMPARATIVE STUDY; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT; WHEY;

ANIMALS; CELL DIVISION; FEMALE; GLUTATHIONE; HUMANS; LEUKOCYTES, MONONUCLEAR; MAMMARY NEOPLASMS, EXPERIMENTAL; MILK PROTEINS; RATS; RATS, INBRED F344; REFERENCE VALUES; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0029957806     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Schecter RL, Woo A, Duong M, and Batist G: In vivo and in vitro mechanisms of drug resistance in a rat mammary carcinoma model Cancer Res 51: 1434-1442, 1991
2. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC and Anderson ME: High resistance to cisplatin in human ovarian cancer cell lines is associated with increase of glutathione synthesis. Proc Natl Acad Sci USA 89: 3070-3074, 1992.
3. leister A: Selective modulation of glutathione metabolism. Science 22: 471-477, 1983.
4. Meister A: Glutathione deficiency produced by inhibition of its synthesis and its reversal: application in research and therapy. Pharmac Ther 51: 155-194, 1991.
5. Meister A, Anderson, ME and Huang O: Intracellular cysteine and glutathione delivery system. J Am Coll Nutr 5: 137-151, 1986.
6. Hamilton TC, Lai GM, and Rosenberg ML: Mechanism of resistance to alkylating agent and cisplatin Cancer Treatment and Research-Drug resistance (Ed Ozols) pp.151-169. Marinus Nijhoff, Boston 1989.
7. Russo A, de Graft W, Frieman N and Mitchell JB: Selective modulation of glutathione levels inhuman normal versus tumor cells and subsequent differential response to chemotherapy drugs Cancer Res 46, 2845-28 18, 1986.
8. Roberts JC and Francetic DJ: Time course for elevation of glutathione in numerous organs of L210-bearing CDF1 mice given L-cysteine prodrug Ribcystine. Toxicol Lett 59: 245-251, 1991.
9. Teitze F: Enzymatic method for quantitative determinations of nanograms amount of total and oxidized glutathione Application to mammalian blood and other tissues. Anal Biochem 27 502-522, 1989.
10. Bourtourault M, Buleon R, Samperes S Jouan: Effet des pioteines du lactoserum bovin sur la multiplication des cellules cancereuses humames. CR Soc Biol 185: 319-323, 1991
11. Lauren L, Briand P, Lykkesfdt AE: Serum albumin as a modulator of growth of the human breast cancer cell line MCF-7. Anticancer Res 10 343-352, 1990.
12. Hakanson A, Zhivotovsky B, Orenius S, Sabhanval H, and Svanborg C: Apoptosis induced by a human milk protein. Proc Natl Acad. Sci USA 92: 8064-8068, 1995.
13. Bezault J, Bhimani R, Wipowitch J, Furmanski P: Human lactoferrin inhibits the growth of solid tumors and development of experimental metastasis in mice Cancer Res 54: 2310-2312, 1994.
14. Booselaers E, Caessens PW, Van Boekel MA: Different effects of milk proteins. BSA and soy on 4NQO or MNNG induced SCE in V79 cells. Food Chem Toxicol 32: 905-909, 1994.
15. Bounous G, Gold P: The biological activity of nondenaturated whey protein concentrate. Role of Glutathione. Clin and Invest Med 14: 296-309, 1991.
16. Bounous G, Papenburg R, Kongshavn PAL, Gold P: Dietary whey protein inhibits the development of dimethylhydrazine induced malignancies. Clin Invest Med 11 213-217, 1988.
17. McIntosh G, Register G, Leleu R, Royle P, Smithers G: Dairy proteins protect against Dimethylhydrazineinduced intestinal cancers in Rats. J Nutr 125: 809-816, 1995.
18. Baruchel S, Wang T, Farah R, Jamali M, and Batist G: In vivo selective modulation of tissue alutathione in a rat mammary carcinoma model. Biochem. Pharmac. 50: 9; 1505-1508, 1995
19. Kennedy RS, Konnock O, Bounous G, Baruchel S, Lee T: The use of Whey Protein Concentrate in the treatment of patients with metastatic carcinoma: A phase I-II clinical study. Anticancer Res. November/December. In press 1995.
20. Hercberg A, Brock-Simoni F, Hotzman F: Erythrocyte glutathione and tumor response to chemotherapy. Lancet 339: 1071-1076, 1992.